LONA
LeonaBio, Inc.
Price Chart
Latest Quote
$8.59
+0.24 (+2.87%)
Current Price
| Previous Close | $8.35 |
| Open | $8.32 |
| Day High | $8.78 |
| Day Low | $8.32 |
| Volume | 5,416 |
Stock Information
| Shares Outstanding | 9.39M |
| Total Debt | $691K |
| Cash Equivalents | $67.68M |
| Net Income | $-129.41M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $80.69M |
| EPS (TTM) | $-24.09 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $13.70M |
| Income | $-129.41M |
| Book/sh | $5.25 |
| Cash/sh | $7.20 |
| Employees | 19 |
Financial Ratios
| Quick Ratio | 10.15 |
| Current Ratio | 10.38 |
| Debt/Eq | 1.40 |
Returns & Margins
| ROA | -46.46% |
| ROE | -298.76% |
Ownership
| Insider Ownership | 4.51% |
| Institutional Ownership | 70.44% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 1.64 |
Analyst Data
| Recommendation | none |
| Target Price | $18.00 |
Technical Indicators
| SMA20 | $8.65 |
| SMA50 | $9.17 |
| SMA200 | $6.48 |
| RSI | 49.24 |
| ATR | 0.5258 |
| Shares Float | 5.62M |
| Short Float | 0.77% |
| Short Ratio | 1.36 |
| Volatility | 2.02 |
| Rel Volume | 0.36 |
Performance History
| Week | +9.01% |
| Month | -16.84% |
| Quarter | -4.77% |
| 6 Months | +23.24% |
| YTD | +23.42% |
| Year | +190.20% |
| 3 Years | -70.88% |
| 5 Years | -95.37% |
| 10 Years | -94.98% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $8.59 | 6,100 |
| 2026-06-23 | $8.35 | 4,100 |
| 2026-06-22 | $8.27 | 21,900 |
| 2026-06-18 | $8.18 | 8,600 |
| 2026-06-17 | $8.23 | 12,000 |
| 2026-06-16 | $7.88 | 25,400 |
| 2026-06-15 | $8.45 | 7,700 |
| 2026-06-12 | $8.35 | 15,600 |
| 2026-06-11 | $8.49 | 12,400 |
| 2026-06-10 | $8.43 | 13,000 |
| 2026-06-09 | $8.46 | 20,600 |
| 2026-06-08 | $8.59 | 12,900 |
| 2026-06-05 | $8.22 | 16,000 |
| 2026-06-04 | $8.61 | 18,500 |
| 2026-06-03 | $8.63 | 37,500 |
| 2026-06-02 | $9.02 | 20,600 |
| 2026-06-01 | $9.29 | 19,700 |
| 2026-05-29 | $9.54 | 9,800 |
| 2026-05-28 | $9.64 | 5,200 |
| 2026-05-27 | $9.81 | 51,200 |
| 2026-05-26 | $9.67 | 88,600 |
About LeonaBio, Inc.
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company's lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of diabetic neuropathy, which is in phase 1 clinical trial; and ATH-1017 for the treatment of Alzheimer's disease and Parkinson's disease, which is in phase 2 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
đ° Latest News
No news articles available at the moment. Check back later for updates on LONA.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $34,178,000 | $96,775,000 | $126,937,000 | $88,855,000 |
| Other Income Expense | $-71,431,000 | $-165,000 | $9,265,000 | $-6,784,000 |
| Other Non Operating Income Expenses | $1,236,000 | $3,962,000 | $7,637,000 | $3,216,000 |
| Operating Expense | $34,178,000 | $96,775,000 | $126,937,000 | $88,855,000 |
| General And Administrative Expense | $16,678,000 | $26,093,000 | $33,304,000 | $32,552,000 |
| Other Operating Expenses | - | - | $-157,000 | $-5,161,000 |
| Interest Expense | - | - | - | - |
| Net Non Operating Interest Income Expense | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-105,609,000 | $-96,940,000 | $-117,672,000 | $-95,639,000 |
| Normalized Income | $-32,942,000 | $-92,813,000 | $-119,300,000 | $-85,639,000 |
| Net Income From Continuing And Discontinued Operation | $-105,609,000 | $-96,940,000 | $-117,672,000 | $-95,639,000 |
| Total Operating Income As Reported | $-102,266,000 | $-100,902,000 | $-125,466,000 | $-104,016,000 |
| Net Income Common Stockholders | $-105,609,000 | $-96,940,000 | $-117,672,000 | $-95,639,000 |
| Net Income | $-105,609,000 | $-96,940,000 | $-117,672,000 | $-95,639,000 |
| Net Income Including Noncontrolling Interests | $-105,609,000 | $-96,940,000 | $-117,672,000 | $-95,639,000 |
| Net Income Continuous Operations | $-105,609,000 | $-96,940,000 | $-117,672,000 | $-95,639,000 |
| Pretax Income | $-105,609,000 | $-96,940,000 | $-117,672,000 | $-95,639,000 |
| Special Income Charges | $-68,088,000 | $-4,127,000 | $1,628,000 | $-10,000,000 |
| Operating Income | $-34,178,000 | $-96,775,000 | $-126,937,000 | $-88,855,000 |
| Net Interest Income | - | - | - | - |
| Interest Income | - | - | - | - |
| Interest Income Non Operating | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-24.70 | $-25.20 | $-30.90 | $-25.30 |
| Basic EPS | $-24.70 | $-25.20 | $-30.90 | $-25.30 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $39,461,000 | $-91,678,000 | $-127,596,000 | $-78,010,000 |
| Total Unusual Items | $-72,667,000 | $-4,127,000 | $1,628,000 | $-10,000,000 |
| Total Unusual Items Excluding Goodwill | $-72,667,000 | $-4,127,000 | $1,628,000 | $-10,000,000 |
| Reconciled Depreciation | $972,000 | $970,000 | $969,000 | $845,000 |
| EBITDA (Bullshit earnings) | $-33,206,000 | $-95,805,000 | $-125,968,000 | $-88,010,000 |
| EBIT | $-34,178,000 | $-96,775,000 | $-126,937,000 | $-88,855,000 |
| Diluted Average Shares | $4,275,762 | $3,848,087 | $3,802,018 | $3,773,324 |
| Basic Average Shares | $4,275,762 | $3,848,087 | $3,802,018 | $3,773,324 |
| Diluted NI Availto Com Stockholders | $-105,609,000 | $-96,940,000 | $-117,672,000 | $-95,639,000 |
| Other Special Charges | $68,088,000 | $4,127,000 | $-1,628,000 | $10,000,000 |
| Gain On Sale Of Security | $-4,579,000 | - | - | - |
| Research And Development | $17,500,000 | $70,682,000 | $93,790,000 | $61,464,000 |
| Selling General And Administration | $16,678,000 | $26,093,000 | $33,304,000 | $32,552,000 |
| Other Gand A | $16,678,000 | $26,093,000 | $33,304,000 | $32,552,000 |
| Otherunder Preferred Stock Dividend | - | - | - | $1,568,000 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $27,790,000 | $44,841,000 | $130,188,000 | $235,137,000 |
| Total Assets | $92,151,000 | $58,779,000 | $160,245,000 | $258,153,000 |
| Total Non Current Assets | $2,693,000 | $3,938,000 | $5,516,000 | $50,620,000 |
| Other Non Current Assets | $686,000 | $686,000 | $1,079,000 | $475,000 |
| Current Assets | $89,458,000 | $54,841,000 | $154,729,000 | $207,533,000 |
| Other Current Assets | $1,127,000 | $3,566,000 | $5,682,000 | $5,962,000 |
| Cash Cash Equivalents And Short Term Investments | $88,331,000 | $51,275,000 | $147,419,000 | $200,344,000 |
| Cash And Cash Equivalents | $69,276,000 | $48,438,000 | $90,584,000 | $95,966,000 |
| Receivables | - | $0 | $1,628,000 | $1,227,000 |
| Investmentin Financial Assets | - | - | $0 | $44,829,000 |
| Other Receivables | - | - | $1,628,000 | $1,227,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $803,000 | $1,217,000 | $1,585,000 | $1,911,000 |
| Long Term Debt And Capital Lease Obligation | $338,000 | $803,000 | $1,217,000 | $1,585,000 |
| Current Debt And Capital Lease Obligation | $465,000 | $414,000 | $368,000 | $326,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $64,361,000 | $13,938,000 | $30,057,000 | $23,016,000 |
| Total Non Current Liabilities Net Minority Interest | $16,858,000 | $803,000 | $1,217,000 | $1,585,000 |
| Other Non Current Liabilities | $16,520,000 | - | - | - |
| Current Liabilities | $47,503,000 | $13,135,000 | $28,840,000 | $21,431,000 |
| Other Current Liabilities | $37,488,000 | - | - | - |
| Payables And Accrued Expenses | $7,602,000 | $9,731,000 | $23,927,000 | $17,690,000 |
| Payables | $4,587,000 | $319,000 | $129,000 | $2,501,000 |
| Accounts Payable | $4,587,000 | $319,000 | $129,000 | $2,501,000 |
| Equity | ||||
| Common Stock Equity | $27,790,000 | $44,841,000 | $130,188,000 | $235,137,000 |
| Total Equity Gross Minority Interest | $27,790,000 | $44,841,000 | $130,188,000 | $235,137,000 |
| Stockholders Equity | $27,790,000 | $44,841,000 | $130,188,000 | $235,137,000 |
| Gains Losses Not Affecting Retained Earnings | $-4,000 | $1,000 | $-349,000 | $-1,956,000 |
| Other Equity Adjustments | $-4,000 | $1,000 | $-349,000 | $-1,956,000 |
| Retained Earnings | $-511,755,000 | $-406,146,000 | $-309,206,000 | $-191,534,000 |
| Other | ||||
| Ordinary Shares Number | $9,335,913 | $3,904,094 | $3,817,260 | $3,787,738 |
| Share Issued | $9,335,913 | $3,904,094 | $3,817,260 | $3,787,738 |
| Tangible Book Value | $27,790,000 | $44,841,000 | $130,188,000 | $235,137,000 |
| Invested Capital | $27,790,000 | $44,841,000 | $130,188,000 | $235,137,000 |
| Working Capital | $41,955,000 | $41,706,000 | $125,889,000 | $186,102,000 |
| Capital Lease Obligations | $803,000 | $1,217,000 | $1,585,000 | $1,911,000 |
| Total Capitalization | $27,790,000 | $44,841,000 | $130,188,000 | $235,137,000 |
| Additional Paid In Capital | $539,548,000 | $450,986,000 | $439,739,000 | $428,623,000 |
| Capital Stock | $1,000 | $0 | $4,000 | $4,000 |
| Common Stock | $1,000 | $0 | $4,000 | $4,000 |
| Long Term Capital Lease Obligation | $338,000 | $803,000 | $1,217,000 | $1,585,000 |
| Current Capital Lease Obligation | $465,000 | $414,000 | $368,000 | $326,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,948,000 | $2,990,000 | $4,545,000 | $3,415,000 |
| Current Accrued Expenses | $3,015,000 | $9,412,000 | $23,798,000 | $15,189,000 |
| Net PPE | $2,007,000 | $3,252,000 | $4,437,000 | $5,316,000 |
| Accumulated Depreciation | $-4,267,000 | $-3,295,000 | $-2,334,000 | $-1,368,000 |
| Gross PPE | $6,274,000 | $6,547,000 | $6,771,000 | $6,684,000 |
| Leases | $4,322,000 | $4,322,000 | $4,322,000 | $4,296,000 |
| Other Properties | $1,240,000 | $1,513,000 | $1,737,000 | $1,696,000 |
| Machinery Furniture Equipment | $712,000 | $712,000 | $712,000 | $692,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $19,055,000 | $2,837,000 | $56,835,000 | $104,378,000 |
| Treasury Shares Number | - | - | $0 | - |
| Investments And Advances | - | - | $0 | $44,829,000 |
| Construction In Progress | - | - | - | $0 |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-45,729,000 | $-97,203,000 | $-101,057,000 | $-73,610,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-45,729,000 | $-97,170,000 | $-100,753,000 | $-72,469,000 |
| Cash Flow From Continuing Operating Activities | $-45,729,000 | $-97,170,000 | $-100,753,000 | $-72,469,000 |
| Operating Gains Losses | $4,579,000 | $7,000 | - | - |
| Investing Activities | ||||
| Investing Cash Flow | $-15,894,000 | $54,830,000 | $95,089,000 | $57,664,000 |
| Cash Flow From Continuing Investing Activities | $-15,894,000 | $54,830,000 | $95,089,000 | $57,664,000 |
| Capital Expenditure | - | $-33,000 | $-304,000 | $-1,141,000 |
| Financing Activities | ||||
| Financing Cash Flow | $82,461,000 | $194,000 | $493,000 | $654,000 |
| Cash Flow From Continuing Financing Activities | $82,461,000 | $194,000 | $493,000 | $654,000 |
| Net Other Financing Charges | $82,424,000 | - | - | - |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| End Cash Position | $69,907,000 | $49,069,000 | $91,215,000 | $96,386,000 |
| Beginning Cash Position | $49,069,000 | $91,215,000 | $96,386,000 | $110,537,000 |
| Changes In Cash | $20,838,000 | $-42,146,000 | $-5,171,000 | $-14,151,000 |
| Proceeds From Stock Option Exercised | $37,000 | $194,000 | $493,000 | $654,000 |
| Net Investment Purchase And Sale | $-15,894,000 | $54,863,000 | $95,393,000 | $58,805,000 |
| Sale Of Investment | $21,749,000 | $68,997,000 | $123,064,000 | $154,093,000 |
| Purchase Of Investment | $-37,643,000 | $-14,134,000 | $-27,671,000 | $-95,288,000 |
| Net PPE Purchase And Sale | $0 | $-33,000 | $-304,000 | $-1,141,000 |
| Purchase Of PPE | $0 | $-33,000 | $-304,000 | $-1,141,000 |
| Change In Working Capital | $-19,376,000 | $-11,982,000 | $6,527,000 | $11,938,000 |
| Change In Other Current Liabilities | $-473,000 | $-368,000 | $-326,000 | $-15,000 |
| Change In Payables And Accrued Expense | $-21,342,000 | $-15,751,000 | $7,367,000 | $12,101,000 |
| Change In Accrued Expense | $0 | $-10,000,000 | $0 | $10,000,000 |
| Change In Payable | $-21,342,000 | $-5,751,000 | $7,367,000 | $2,101,000 |
| Change In Account Payable | $-21,342,000 | $-5,751,000 | $7,367,000 | $2,101,000 |
| Change In Prepaid Assets | $2,439,000 | $2,509,000 | $-113,000 | $-1,257,000 |
| Change In Receivables | $0 | $1,628,000 | $-401,000 | $1,109,000 |
| Other Non Cash Items | $67,932,000 | $241,000 | $214,000 | $203,000 |
| Stock Based Compensation | $6,102,000 | $11,049,000 | $10,623,000 | $10,606,000 |
| Amortization Of Securities | $-329,000 | $-515,000 | $-1,414,000 | $-422,000 |
| Depreciation Amortization Depletion | $972,000 | $970,000 | $969,000 | $845,000 |
| Depreciation And Amortization | $972,000 | $970,000 | $969,000 | $845,000 |
| Depreciation | $972,000 | $970,000 | $969,000 | $845,000 |
| Gain Loss On Investment Securities | $4,579,000 | - | - | - |
| Gain Loss On Sale Of PPE | $0 | $7,000 | $0 | - |
| Net Income From Continuing Operations | $-105,609,000 | $-96,940,000 | $-117,672,000 | $-95,639,000 |
| Issuance Of Debt | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-23